Cencora
CORCencora is a leading global pharmaceutical sourcing and distribution services provider that bridges the gap between manufacturers and healthcare providers.
Earnings
Next report
Aug 5, 2026 (In 3 weeks)Financials
Q2 2026Valuation & ratios
Segments
Competitors
By market cap
By revenue growth
Profile
Cencora is a leading global pharmaceutical sourcing and distribution services provider that bridges the gap between manufacturers and healthcare providers. The company optimizes the pharmaceutical supply chain by delivering brand-name, generic, and specialty medications alongside clinical and commercialization services. Its core value proposition lies in enhancing patient access to care while improving operational efficiency for both human and animal health markets.
Cencora is one of the three largest national pharmaceutical distributors in the U.S. and maintains a leading global position in specialty logistics and international wholesale.
Questions, answered.
- What is Cencora's market cap?
- Cencora (COR) has a market capitalization of $60.2B and trades on NYSE.
- What is Cencora's revenue and profitability?
- Cencora generated $328.68B in trailing twelve-month revenue with net income of $3.6B, representing a net margin of 0.6%. Gross margin stands at 3.8%. These figures are based on the Q1 2026 filing.
- Who are Cencora's competitors?
- Cencora's key competitors include Cardinal Health, Inc., McKesson Corporation, UPS Logistics, and others. These companies compete in similar markets and product categories.
- Who does Cencora partner with?
- Cencora's notable partners include Walgreens Boots Alliance, Evernorth Health Services, TPG Inc., and others.
- What subsidiaries does Cencora have?
- Cencora's subsidiaries include Retina Consultants of America, Alliance Healthcare, World Courier, and others.
- Where is Cencora headquartered?
- Cencora is headquartered in United States of America and employs approximately 46,000 people. It has been publicly traded since 1995.
